Strong Financial Performance
Tenet Healthcare reported operating revenues of $20.7 billion and consolidated adjusted EBITDA of $4 billion for 2024, representing a 13% growth over 2023.
Improved EBITDA Margin
Full-year adjusted EBITDA margin improved by over 200 basis points to 19.3% compared to the previous year.
USPI Segment Growth
USPI generated $1.81 billion in adjusted EBITDA in 2024, marking a 17% growth over 2023, with adjusted EBITDA margins of 42.1%.
Hospital Segment Performance
Despite the sale of 14 hospitals, the Hospital segment achieved $2.185 billion of adjusted EBITDA in 2024, a 9% increase over the prior year.
Significant Share Repurchase
Tenet returned capital to shareholders by repurchasing approximately 14% of its outstanding shares for $1.12 billion since the fourth quarter of 2022.
Deleveraged Balance Sheet
Year-end leverage ratio improved to 2.5x EBITDA, supported by hospital divestitures and strong operational performance.